Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome

NCT: NCT06342999 · ENROLLING_BY_INVITATION

NCT IDNCT06342999
StatusENROLLING_BY_INVITATION
Start Date2027-01-01
Completion2036-07

Brief Summary

The purpose of this research is to investigate the best way to manage evolving hypoplastic left heart syndrome (HLHS).

Frequently Asked Questions

What is Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome?

Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome is a clinical trial registered under NCT06342999. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT06342999?

The current status of NCT06342999 (Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome) is: ENROLLING_BY_INVITATION.

When did Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome start?

Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome started on 2027-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑